GVHIB Stock UPDATES Global Vision Holdings Inc. Cl B (GVHIB)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Global Vision Holdings Inc. Cl B (GVHIB) 0.0046 $GVHIB

Global Vision Holdings Inc. Reports Growth for Subsidiary: The Place Media
ACCESSWIRE - Wed Jul 30, 12:50PM CDT
IRVINE, CA / ACCESSWIRE / July 30, 2014 / Global Vision Holdings Inc. (OTCQB: GVHIB) is a diversified financial holding company focusing on investments in environmentally responsible, profitable and growing companies.

Global Vision Holdings Inc. (OTCQB: GVHIB) is a Diversified Financial Holding Company Focusing on Investments in Environmentally Responsible, Profitable and Growing Companies
ACCESSWIRE - Thu Jul 24, 6:58PM CDT
IRVINE, CA / ACCESSWIRE / July 24, 2014 / Global Vision Holdings Inc. (OTCQB: GVHIB) is a diversified financial holding company focusing on investments in environmentally responsible, profitable and growing companies.

Global Vision Holdings Inc. (OTCQB: GVHIB) is a diversified financial holding company focusing on investments in environmentally responsible, profitable and growing companies.
eTeligis - Thu Jul 24, 6:50PM CDT
IRVINE, CA, United States, via eTeligis Inc., 07/24/2014 - - Mama's Best, a subsidiary of Global Vision, produces high quality organic sauces, marinades, soups, and spreads. After the incredible response of rolling out Mama's Best jams to Sprouts and Whole Foods, the consumer response exploded. This has lead Mama's Best into a new research and development stage of their company. The company is focusing on 5-10 new products such as five soups, two chimichurri sauces, four salad dressings and additional products. Glen Carnes, CEO and Chairman of Global Vision Holdings, Inc., which owns Mamma's Best, states "I am enthusiastic to roll out more of Mama's Best Products to it's consumers. We value the loyalty of our customer base and I look forward to sharing our products with the shopper."

Global Vision Holdings, Inc. Signed Letter of Intent to Acquire Art Masters, Inc.
Marketwire - Fri Feb 07, 4:42AM CST
Global Vision Holdings, Inc. (OTCQB: GVHIB), a diversified holding company focusing on environmentally responsible, profitable and growing companies, announced today that they have signed a letter of intent to purchase 100 percent of Art Masters, Inc.

PharmaPoint Report: Hemophilia A and B - US Drug Forecast and Market Analysis to 2022
M2 - Tue Feb 04, 9:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/jvp3hs/pharmapoint) has announced the addition of the "PharmaPoint: Hemophilia A and B - US Drug Forecast and Market Analysis to 2022" report to their offering. The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through adulthood. However, the burden on patients and their families to maintain the prophylactic treatment schedule is high, and there is a significant unmet need for new therapies that can reduce the number of weekly prophylactic infusions and alleviate some of this treatment burden. The US is the largest hemophilia market, due to the high rates of disease diagnosis combined with high rates of primary rFVIII and rFIX prophylaxis among diagnosed severe hemophilia A and B patients. Companies such as Baxter, Bayer, Novo Nordisk, CSL Behring and Biogen Idec will be able to command slight premiums over currently marketed recombinant standard of care therapies, thus contributing to overall market growth. Scope - Overview of Hemophilia A and B including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. - Detailed information on the key drugs in the US including product description, safety and efficacy profiles as well as a SWOT analysis. - Sales forecast for the top drugs in the US from 2012-2022. - Analysis of the impact of key events as well the drivers and restraints affecting the US Hemophilia A and B market. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Disease Overview 4 Disease Management 5 Competitive Assessment 5.1 Overview 5.2 Strategic Competitive Assessment 5.3 Product Profiles - Major Brands, Hemophilia A 5.4 Product Profiles - Hemophilia B 5.5 Product Profiles - Hemophilia A and B with Inhibitors 6 Opportunity and Unmet Need 7 Pipeline Assessment 7.1 Overview 7.2 Promising Drugs in Clinical Development - Hemophilia A 7.3 Promising Drugs in Clinical Development - Hemophilia B 7.4 Promising Drugs in Clinical Development - Hemophilia A and B Patients with Inhibitors 8 Market Outlook 9 Appendix For more information visit http://www.researchandmarkets.com/research/jv...harmapoint

Whitebox Advisors Adds Jon Olstein in Strategic Relationships Role
PR Newswire - Thu Jan 23, 1:00PM CST
Today, Whitebox Advisors, an asset management company based in Minneapolis with over $3 billion in AUM (12/31/2013), announced the addition of Jon Olstein as a managing director for strategic relationships based in the New York/Tri-state area.

Global Vision Holdings Inc. Retains the Paradigm Group for Investor Communications
ACCESSWIRE - Wed Jul 03, 9:33AM CDT
IRVINE, CA - (eTeligis via ACCESSWIRE) - Jul 3, 2013 - Global Vision Holdings, Inc. (or the "Company" (OTCBB: GVHIB), a diversified financial holding company focusing on investments in profitable and growing companies, announced today the appointment of the Paradigm Group to assist the Company in attracting new investors and communicating its corporate strategy to shareholders and the investment community.

Global Vision Holdings Increases Distribution with Whole Foods
ACCESSWIRE - Mon Jun 24, 1:30PM CDT
Irvine, CA, June 24, 2013 -- Mamma's Best, a subsidiary of Global Vision Holdings Inc. (OTCQB: GVHIB), a diversified financial holding company focusing on investments in profitable and growing companies, has just finalized a deal with Whole Foods Market in which Mamma's Best sauces and marinades will have additional placement on top of their meat counters and will be used to marinade their meats on display for sale in the meat department.

The Place Magazine Launches New Look
Marketwire - Mon Jun 03, 7:37AM CDT
The Place Media, LLC, a wholly owned subsidiary of Global Vision Holdings, Inc. (OTCQB: GVHIB), a diversified financial holding company focusing on investments in profitable and growing companies, launched an upgraded contemporary look of their publication, The Place Magazine, whose three separate editions cover Southern California, including LA, Orange County and San Diego.

Global Vision Holdings, Inc. Acquires The Place Media
Marketwire - Thu Apr 25, 4:30AM CDT
Global Vision Holdings, Inc. (OTCQB: GVHIB), a diversified financial holding company focusing on investments in profitable and growing companies, announced today it has finalized its acquisition of The Place Media, a travel-based publication company whose magazines cover the LA, Orange County and San Diego areas that make up Southern California. Global Vision Holdings, Inc. closed this Asset Purchase Agreement at a price of $1,000,000.00. The Place Media, LLC, will operate as a wholly owned subsidiary of Global Vision Holdings, Inc.

Global Vision Holdings Subsidiary, Grocers Direct, Partners With Byron Bay Cookies/Luken & May/Falwasser
Marketwire - Wed Mar 27, 7:30AM CDT
Global Vision Holdings, Inc. (OTCQB: GVHIB) a diversified financial holding company focusing on investments in environmentally responsible, profitable and growing companies is pleased to announce that one of its subsidiaries, Grocers Direct LLC, is now in partnership with Byron Bay Cookie Company, Luken & May biscuits, and Falwasser crispbreads. These Australian-based companies are owned by Slater International, run by Gordon Slater.

Global Vision Holdings Obtains Funding From Asher Enterprises
Marketwire - Wed Mar 13, 7:01AM CDT
Global Vision Holdings, Inc. (OTCQB: GVHIB), a diversified financial holding company focusing on investments in profitable and growing companies, announced today it has finalized a funding agreement with Asher Enterprises, a privately owned investment company based in New York that helps emerging businesses achieve their full potential. The agreement provides Global Vision Holdings, Inc. with improved financial flexibility to execute its long-term strategic plan to expand its investment portfolio.

OTC Signal Daily Stock Watch
WorldStockWire - Tue Feb 05, 12:30AM CST
OTC Signal tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Signal at the following: http://www.otcsignal.com

Global Vision Holdings Subsidiary Mamma's Best Launches New Look
Marketwire - Mon Jan 28, 7:09PM CST
Mamma's Best, a subsidiary of Global Vision Holdings Inc. (OTCQB: GVHIB) a diversified financial holding company focusing on investments in environmentally responsible, profitable and growing companies, has updated its look with new labels that give the brand a bolder, more modern feel that sets them apart and allows them to stand out amongst the competition.

Global Vision Holdings Inc. Gave Back for the Holidays
Marketwire - Fri Jan 25, 5:45PM CST
Global Vision Holdings Inc. (OTCQB: GVHIB) a diversified financial holding company focusing on investments in environmentally responsible, profitable and growing companies worked with two of its subsidiaries, Grocers Direct and Mamma's Best, to show community support during this holiday season.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading